Temsirolimus (Torisel) for the indication 'relapsed or refractory mantle cell lymphoma'

This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.

Download "Temsirolimus (Torisel) for the indication 'relapsed or refractory mantle cell lymphoma'"

PDF document | 49 kB

Report | 25-08-2008